To assess whether LCN2 mAb targeted endogenous LCN2 that was induced after stroke, brain homogenates and blood sera of LCN2+/+ and LCN2−/− mice collected before and after tMCAo were analyzed by immunoprecipitation. The gene discussed is LCN2; the disease is stroke disorder.